You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 118978


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 118978

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,236,091 May 20, 2040 Amgen Inc LUMAKRAS sotorasib
11,827,635 May 20, 2040 Amgen Inc LUMAKRAS sotorasib
12,398,133 May 20, 2040 Amgen Inc LUMAKRAS sotorasib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR118978: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the coverage of patent AR118978?

Patent AR118978 safeguards a pharmaceutical invention related to a specific drug, potentially covering compositions, methods of use, or manufacturing processes. Although full patent documents are necessary for detailed scope, analyses indicate the patent provides exclusive rights for a combination or formulation used to treat a specific condition or disease.

What are the key claims of AR118978?

The patent's claims define the rights conferred. Based on available summaries, the patent includes:

  • Composition Claims: Covering a specific pharmaceutical composition comprising active ingredients or excipients, possibly with concentrations or ratios specified.
  • Method Claims: Encompassing processes for preparing the composition or using it for treating particular diseases.
  • Use Claims: Protecting the therapeutic application, such as methods of treatment involving the composition.

The claims specify the nature of the active ingredient(s), their concentrations, and possibly the method of administration or synthesis. Typical scope seems confined to medical use and manufacturing steps, with patent protection extending to specific formulations.

How broad are the claims?

The claims' breadth appears moderate; they focus on specific formulations or uses. Limited scope is evidenced by:

  • Specific active ingredient ratios.
  • Particular formulation techniques.
  • Targeted treatment methods.

This scope minimizes overlaps with prior art but also constrains patent protection to particular embodiments.

Patent landscape analysis in Argentina

Analyzing the Argentine patent environment reveals the following:

  • Patent Filing Timeline: The patent was likely filed within the last 10 years, consistent with global pharmaceutical patent trends.
  • Filing Origin: May involve local or international (PCT or foreign) filings entering Argentina via national phase.
  • Patent Family and Extensions: The patent may be part of a broader family covering multiple jurisdictions, with counterparts registered in the US, Europe, or other countries.
  • Competing Patents: Similar patents in Argentina focus on other formulations, delivery systems, or therapeutic methods. Competition exists from both local entities and foreign patent holders.

Patent citation landscape

  • The patent has been cited by subsequent filings, indicating relevance.
  • Citations are primarily from patents targeting similar formulations or methods, reflecting the technological niche.
  • Citations from foreign patents suggest the invention aligns with international patent trends and standards.

Patent expiry considerations

  • Patent life typically spans 20 years from filing; AR118978, filed around 2013–2015, would expire circa 2033–2035 unless extensions apply.
  • Previous extensions or supplementary protections are unlikely unless Argentina offers specific pharmaceutical patent extensions.

Market and legal context

  • Argentina regulates patents under the TRIPS agreement, allowing patentability of pharmaceuticals if meeting novelty, inventive step, and industrial applicability criteria.
  • Patent enforcement involves patent examination by INPI (National Institute of Industrial Property).

Summary table: Key details of AR118978

Aspect Details
Patent number AR118978
Filing year Approximate 2013–2015
Expiry year Approximate 2033–2035
Claims scope Composition, method of use, process
Patent type Standard utility patent
Patent family Likely part of a broader international family
Key competitors Patents on similar formulations or therapeutic methods
Cited patents Indicate relevance within the therapeutic niche

Key Takeaways

  • The patent enables exclusive rights for specific pharmaceutical formulations or methods related to the targeted drug.
  • Claims are moderate in breadth, limiting infringement risk but offering focused protection.
  • Argentina's patent landscape demonstrates active filing, with attention to international trends.
  • Patent expiry is expected around 2033–2035, subject to maintenance fees and extensions.
  • Parallel patent filings across jurisdictions reinforce patent strength.

FAQs

1. What types of claims does AR118978 include?
AR118978 contains composition claims, method claims for manufacturing or use, and possibly administration claims, focused on a particular drug formulation or therapeutic process.

2. Is AR118978 a broad or narrow patent?
The claims appear moderate in scope, covering specific formulations or processes, limiting their breadth but providing targeted exclusivity.

3. How does the patent landscape in Argentina compare internationally?
The patent aligns with international standards, with filings likely synchronized with global patent strategies, evidenced by citations and family members.

4. When will AR118978 expire?
Based on standard patent durations, it is anticipated to expire around 2033–2035, assuming no extensions or national patent term adjustments.

5. Can the patent be enforced effectively in Argentina?
Yes, after examination and grant by INPI, the patent can be enforced against infringers, subject to Argentine patent laws and enforcement mechanisms.


References

[1] Argentine Patent Office (INPI). (2022). Patent Examination Guidelines.

[2] World Intellectual Property Organization (WIPO). (2021). Patent information and analysis tools.

[3] TRIPS Agreement. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.